238 related articles for article (PubMed ID: 25024625)
1. Combination of symptoms, syndrome and disease: treatment of refractory diabetic gastroparesis.
Li JL; Li M; Pang B; Zhou Q; Tian JX; Liu HX; Zhao XY; Tong XL
World J Gastroenterol; 2014 Jul; 20(26):8674-80. PubMed ID: 25024625
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic response to domperidone in gastroparesis: A prospective study using the GCSI-daily diary.
Heckert J; Parkman HP
Neurogastroenterol Motil; 2018 Jan; 30(1):. PubMed ID: 29110425
[TBL] [Abstract][Full Text] [Related]
3. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD).
Revicki DA; Camilleri M; Kuo B; Szarka LA; McCormack J; Parkman HP
Neurogastroenterol Motil; 2012 May; 24(5):456-63, e215-6. PubMed ID: 22284754
[TBL] [Abstract][Full Text] [Related]
4. The American neurogastroenterology and motility society gastroparesis cardinal symptom index-daily diary (ANMS GCSI-DD): Psychometric evaluation in patients with idiopathic or diabetic gastroparesis.
Revicki DA; Speck RM; Lavoie S; Puelles J; Kuo B; Camilleri M; Almansa C; Parkman HP
Neurogastroenterol Motil; 2019 Apr; 31(4):e13553. PubMed ID: 30734412
[TBL] [Abstract][Full Text] [Related]
5. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms.
Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
Qual Life Res; 2004 May; 13(4):833-44. PubMed ID: 15129893
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial.
Carlin JL; Lieberman VR; Dahal A; Keefe MS; Xiao C; Birznieks G; Abell TL; Lembo A; Parkman HP; Polymeropoulos MH
Gastroenterology; 2021 Jan; 160(1):76-87.e4. PubMed ID: 32693185
[TBL] [Abstract][Full Text] [Related]
7. Domperidone to Treat Symptoms of Gastroparesis: Benefits and Side Effects from a Large Single-Center Cohort.
Schey R; Saadi M; Midani D; Roberts AC; Parupalli R; Parkman HP
Dig Dis Sci; 2016 Dec; 61(12):3545-3551. PubMed ID: 27530760
[TBL] [Abstract][Full Text] [Related]
8. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors.
Anaparthy R; Pehlivanov N; Grady J; Yimei H; Pasricha PJ
Dig Dis Sci; 2009 May; 54(5):1003-10. PubMed ID: 19277867
[TBL] [Abstract][Full Text] [Related]
9. Itopride and pantoprazole outcomes in diabetic gastroparesis trial (IPOD trial).
Venkatesh V; Kulkarni KP
J Indian Med Assoc; 2008 Dec; 106(12):814-5. PubMed ID: 19370958
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of gastric electrical stimulation in gastroparesis: Results from a large prospectively collected database of national gastroparesis registries.
Abell TL; Yamada G; McCallum RW; Van Natta ML; Tonascia J; Parkman HP; Koch KL; Sarosiek I; Farrugia G; Grover M; Hasler W; Nguyen L; Snape W; Kuo B; Shulman R; Hamilton FA; Pasricha PJ
Neurogastroenterol Motil; 2019 Dec; 31(12):e13714. PubMed ID: 31584238
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.
Revicki DA; Rentz AM; Dubois D; Kahrilas P; Stanghellini V; Talley NJ; Tack J
Aliment Pharmacol Ther; 2003 Jul; 18(1):141-50. PubMed ID: 12848636
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
Camilleri M; McCallum RW; Tack J; Spence SC; Gottesdiener K; Fiedorek FT
Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis.
Maranki JL; Lytes V; Meilahn JE; Harbison S; Friedenberg FK; Fisher RS; Parkman HP
Dig Dis Sci; 2008 Aug; 53(8):2072-8. PubMed ID: 18080765
[TBL] [Abstract][Full Text] [Related]
14. Gastroparesis-associated refractory nausea treated with aprepitant.
Fahler J; Wall GC; Leman BI
Ann Pharmacother; 2012 Dec; 46(12):e38. PubMed ID: 23191934
[TBL] [Abstract][Full Text] [Related]
15. Gastroparesis-Related Symptoms in Patients With Type 2 Diabetes Mellitus: Early Detection, Risk Factors, and Prevalence.
Asghar S; Asghar S; Shahid S; Sajjad H; Abdul Nasir J; Usman M
Cureus; 2023 Mar; 15(3):e35787. PubMed ID: 37025723
[TBL] [Abstract][Full Text] [Related]
16. Symptom variability throughout the day in patients with gastroparesis.
Shahsavari D; Yu D; Jehangir A; Lu X; Zoll B; Parkman HP
Neurogastroenterol Motil; 2020 Feb; 32(2):e13740. PubMed ID: 31782211
[TBL] [Abstract][Full Text] [Related]
17. Development and content validity of a gastroparesis cardinal symptom index daily diary.
Revicki DA; Camilleri M; Kuo B; Norton NJ; Murray L; Palsgrove A; Parkman HP
Aliment Pharmacol Ther; 2009 Sep; 30(6):670-80. PubMed ID: 19558608
[TBL] [Abstract][Full Text] [Related]
18. Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study.
Midani D; Parkman HP
J Neurogastroenterol Motil; 2016 Oct; 22(4):650-655. PubMed ID: 27400689
[TBL] [Abstract][Full Text] [Related]
19. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
20. Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.
Simmons K; Parkman HP
Dig Dis Sci; 2014 Jun; 59(6):1231-4. PubMed ID: 24615549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
